A new Era in
Cellular Engineering
Safer, precise and more effective
IN-VIVO • CELL-TARGETED • HUMAN PROTEIN-BASED
IN-vivo & cell-TArgeted

Reprograming an individual's own cells within their body for safer and more natural interventions.

Our in vivo engineering platform enables precise and efficient delivery of therapeutic molecules to specific cell types, adaptable across a range of medical applications. We provide flexible solutions to address diverse clinical needs with safety and precision.

NON-VIRAL and HUMAN-BASED

Highly personalized and less intrusive treatments

Our innovative human-based platform ensures that our interventions are perfectly synchronized with human physiology for unmatched effectiveness and safety, reshaping the way to approach health. 

NON-INtegrative

We do not alter your cells. We teach them how to restore proper function or adapt to specific needs.

Our platform does not integrate new genes in your genome; instead, our approach focuses on transient cell modulation without causing permanent genetic alterations. By delivering precise therapeutic instructions, we reprogram cells to restore proper function or adapt to specific needs. This temporary and reversible method ensures safety while enabling cells to perform optimally, addressing a wide range of clinical challenges with flexibility and precision.

Modular
Cellular Engineering
Platform

At DNAmic, we are pioneering the future of cellular engineering with our state-of-the-art platform. Our platform is underpinned by advanced self-assembling structures, meticulously designed to transport therapeutic molecules directly to the cells that need them most, reprogramming them to restore proper function or adapt to specific needs..

Self-assembling structures designed to transport therapeutic molecules directly to the cells that need them most, reprogramming them into a healthier and youthful state.

Core
Precision Delivery with Self-Assembling Proteins
The DNAmic platform utilizes reprogrammed proteins that encapsulate and safeguard therapeutic molecules, ensuring they reach their target cells without compromise. This targeted approach enables a new level of precision in cellular therapy
Reprogrammed proteins that encapsulate and safeguard therapeutic molecules.
Unmatched Biocompatibility
Crafted from human proteins that seamlessly integrate with human biology, our platform is engineered to reduce immune responses and adverse reactions.
Crafted from human proteins that seamlessly integrate with human biology.
More info
Cargo
Exceptional cargo capacity
Thanks to its exceptional cargo capacity - more than 12,000 bases - the system can transport single or multiple payloads within a single nanocarrier, enabling morecomplex and effective treatments.
Transient modification of cellular behavior—without altering the DNA.
Expansive Therapeutic Horizons
Capable of carrying various therapeutic molecules — including nucleic acids and proteins — the DNAmic platform offers a broad spectrum of applications. This versatility positions us at the forefront of cellular engineering and regenerative medicine.
Capable of carrying various therapeutic molecules offering a broad spectrum of applications.
More info
Envelope
Sophisticated Targeting System
By customizing the surface of our DNAmic structures with specific ligands, we achieve unparalleled accuracy in delivering treatments directly to the affected cell types,tissues, and organs, enhancing therapeutic outcomes while minimizing side effects.
Unparalleled accuracy in delivering treatments directly to the affected cell types, tissues, and organs.
Optimized Cellular Uptake
Our structures are endowed with unique properties that enhance their absorption by target cells, ensuring that therapeutic agents are not just delivered but are also effectively utilized by the body, maximizing their healing potential.
Our structures are endowed with unique properties that enhance their absorption by target cells.
More info

"With the ability to precisely target cells, encapsulate large and complex therapeutic cargos, and deliver them safely in vivo to the specific cells, we are opening a new era in gene and cell therapy. Our system provides the missing link that allows researchers to focus on designing the best therapeutic molecules and selecting the right target cells—while our platform takes care of the delivery."

Jesus Beltran, PhD.

CSO and CO-Founder DNamic

PIPELINE

While the technology itself is broadly applicable, we are actively developing therapies in four key areas In-House

Our development pipeline is focused on diseases where in vivo cell engineering can bringtransformative benefits. Current indications include hematologic malignancies, severeautoimmune disorders, and infectious diseases, as well as novel strategies for age-relatedconditions.

More info
Explore More
CORE
Self-Assembling Proteins
Crafted from human proteins that seamlessly integrate with human biology, our platform is engineered to reduce immune responses and adverse reactions.
Explore
CARGO
Expansive Therapeutic Horizons
Capable of carrying various therapeutic molecules — including nucleic acids and proteins — the DNAmic platform offers a broad spectrum of applications.
Explore
ENVELOPE
Sophisticated Targeting System
Unparalleled accuracy in delivering treatments directly to the affected cell types,tissues, and organs, enhancing therapeutic outcomes while minimizing side effects.
Explore
@ 2025 DNAmic BioSystems